RSNA’s $30M policy did not insure against COVID-19 cancellation, judge rules

The Radiological Society of North America is not owed losses it earned after canceling its in-person annual meeting last year due to the COVID-19 pandemic, an Illinois federal judge ruled recently.

U.S. District Judge Robert W. Gettleman pointed to RSNA’s $30 million policy with underwriters at Lloyd’s of London, noting a “clear” communicable disease exclusion in the society’s coverage, Law360 reported July 9.

RSNA had the option to buy communicable disease coverage as part of its event cancellation policy, the news outlet reported, but chose not to.

"The obvious intent is that losses caused by a communicable disease that had been declared a pandemic are excluded from coverage," Judge Gettleman said in the July 8 decision.

The dispute dates back to March, when RSNA accused Llyod’s underwriters of not honoring the event policy, arguing a fair reading of the document resulted in “outright confusion,” according to Law360. In addition to the exclusion, the radiology group said there was also an exception in the policy that made it difficult to determine coverage for communicable diseases.

But Gettleman said that wasn’t the case. He did, however, acknowledge the exclusion contained bad grammar and was poorly written. 

RSNA 2020 was set to take place from November to December at Chicago’s McCormick Place. The in-person cancellation was the first since 1945.

RSNA did not immediately respond to Law360’s request for comment nor an email request from Health Imaging.

Read the full story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup